Crossmark

Formulation Strategy of BCS-II Drugs by Coupling Mechanistic In-Vitro and Nonclinical In-Vivo Data with PBPK: Fundamentals of Absorption-Dissolution to Parameterization of Modelling and Simulation

Crossref DOI link: https://doi.org/10.1208/s12249-025-03093-9

Published Online: 2025-04-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

V A, Shriya

Nayak, Usha Y.

Sathyanarayana, Muddukrishna Badamane

Chaudhari, Bhim Bahadur

Bhat, Krishnamurthy https://orcid.org/0000-0002-8604-472X
Funding

Funding for this research was provided by:

Manipal Academy of Higher Education, Manipal
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 14 October 2024

Accepted: 19 March 2025

First Online: 17 April 2025

Declarations

:

: The authors declare that there is no conflict of interest related to this work.

Document is current

Any future updates will be listed below